A5026815613- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Urologic and reproductive health conditions
- Radiomics and Machine Learning in Medical Imaging
- MRI in cancer diagnosis
- Bladder and Urothelial Cancer Treatments
- Renal cell carcinoma treatment
- Urinary Bladder and Prostate Research
- Advanced X-ray and CT Imaging
- Statistical Methods in Clinical Trials
- Cancer, Lipids, and Metabolism
- Urological Disorders and Treatments
- Parasitic Infections and Diagnostics
- Systemic Sclerosis and Related Diseases
- Advanced MRI Techniques and Applications
- Esophageal Cancer Research and Treatment
- Congenital Anomalies and Fetal Surgery
- Cardiac Imaging and Diagnostics
- Cardiovascular Disease and Adiposity
- Sexual function and dysfunction studies
- Pediatric Urology and Nephrology Studies
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Colorectal Cancer Screening and Detection
- Parasitic infections in humans and animals
- Laser-induced spectroscopy and plasma
Centre Hospitalier Régional Universitaire de Brest
2015-2025
Hôpital Maison Blanche
2020-2024
Université de Bretagne Occidentale
2018-2019
Université Européenne de Bretagne
2019
Université Bretagne Loire
2018
Objective: Compared with standard systematic transrectal ultrasound (TRUS)-guided biopsies (SBx), targeted (TBx) using magnetic resonance imaging (MRI)/TRUS fusion could increase the detection of clinically significant prostate cancer (PCa-s) and reduce non-significant PCa (PCa-ns). This study aimed to compare performance two approaches.Materials methods: A prospective, single-center was conducted on all consecutive patients suspicion who underwent prebiopsy multiparametric MRI (mpMRI)...
ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Schoentgen N, Marolleau J, Delage F, et al. Prospective four years of evaluation erectile function after low-dose-rate prostate brachytherapy using baseline IIEF-5 > 16. Journal Contemporary Brachytherapy. 2019;11(3):195-200. doi:10.5114/jcb.2019.85793. APA Schoentgen, N., Marolleau, J., Delage, F., Coquet, Fourcade, A., & Callerot, P. (2019). Brachytherapy, 11(3), 195-200....
Multiparametric magnetic resonance imaging (MRI) and MRI-targeted biopsy are nowadays recommended in the prostate cancer (PCa) diagnostic pathway. Ploussard Mazzone have integrated these tools into novel risk classification systems predicting of early biochemical recurrence (eBCR) PCa patients who underwent radical prostatectomy (RP). We aimed to assess available define best-performing.Data on 1371 diagnosed by treated RP between 2014 2022 at eight European tertiary referral centers were...